Since 07.07.2021, it is now possible for pharmacies to purchase medical cannabis in pharmaceutical quality via the portal of the Cannabis Agency. The contract to grow the plants was thereby awarded to three companies, which are then distributed via a distribution company commissioned by the BfArM.
Since the introduction of medical cannabis in Germany in 2017, the drug has only been imported and this will continue to take place alongside cultivation in the future. Currently, the German cultivation quantity commissioned as part of an EU-wide procurement process is 10,400 kg over 4 years and this will reach pharmacies at a price of €4.30 per gram, it said. The BfArM explicitly pointed out that the price for the pharmacies only served to cover personnel and material costs and did not generate any surpluses.
Already since the first imports in Germany, QSI has been a strong partner of the medical cannabis industry as a laboratory with narcotics approval and manufacturing authorization. In this context, we also offer, for example, validations of THC rapid tests for your extracts, stability tests or QP-certified batch release tests as part of a full-service analytics.
We congratulate the German medical cannabis producers on this historic moment!
Would you like to learn more about QSI’s services? Please contact our expert directly, we will be happy to support you.
Contact
Dr. Johannes Junemann
Email: johannes.junemann(at)qsi-q3.de
+49 (0) 421-596607-0
Contact
Source: BfArM
